Bristol-Myers Squibb filed suit against Apotex over four patents related to cyclic protein tyrosine kinase inhibitors. 11/23, District of New Jersey, 3:2011cv06918.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
